# MediVR

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medivr

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: www.medivr.jp
- Total disclosed funding: $7.2M
- Latest round: Series B (Jul 9, 2021)
- Investors on record: 5

## About

MediVR Inc. is a Tokyo-based company specializing in the development of VR rehabilitation medical devices. Their innovative products assist in improving patient recovery through advanced virtual reality technology.Founded in 2016, MediVR Inc. operates out of Tokyo, Japan, focusing on VR rehabilitation solutions. Their flagship product, the 'mediVR Kagura,' assesses and enhances rehabilitation outcomes. The founders, Anthea Foong, Han Ng, and Jeremy Ong, have backgrounds in medical technology and innovation. The company has participated in 4 investment deals, with its most recent funding round, Series B, raising JPY 500.000 mn on April 3, 2025, led by MedVenture Partners. Total funding raised to date is JPY 500.000 mn, with a current company valuation of JPY 5442.329 mn.MediVR specializes in VR rehabilitation medical devices, with its premier product, the 'mediVR Kagura.' This apparatus utilizes virtual reality technology to assess and improve key rehabilitation metrics. Targeted towards rehabilitation hospitals, nursing homes, and daycare facilities, it focuses on enhancing skills like posture and balance while minimizing fall risks. The company's commitment is supported by extensive research and patented technologies that bolster VR rehabilitation's effectiveness and acceptance in clinical settings.MediVR primarily generates revenue through sales and leasing of the 'mediVR Kagura' to healthcare institutions. These partnerships often involve a combination of sales and rental agreements, supplemented by comprehensive support services including device demonstrations and ongoing therapist training. Pricing plans are flexible, catering to various client needs, thereby facilitating access to their VR rehabilitation solutions for healthcare providers.MediVR Inc. is focused on expanding its market presence with new product designs slated for release in the upcoming year, aiming to enhance its VR rehabilitation offerings. The company is also targeting new markets beyond Japan, with specific expansion plans to be implemented by 2026, addressing regional healthcare challenges using VR technology. Recent funding of JPY 500.000 mn from Capital Medica Ventures will support these initiatives, enabling MediVR to further its mission and reach within the healthcare sector.

## Funding rounds

- Series B, Jul 9, 2021, $4.5M — Sekisui Chemical, Development Bank of Japan, MedVenture Partners, TARO Ventures
- Series A, Dec 20, 2019, $2.6M — Osaka University Venture Capital, MedVenture Partners, TARO Ventures

## Investors

- Osaka University Venture Capital (https://capitalatlas.ai/funds/osaka-university-venture-capital) — Series A
- MedVenture Partners (https://capitalatlas.ai/funds/medventure-partners) — Series A, Series B
- TARO Ventures (https://capitalatlas.ai/funds/taro-ventures) — Series A, Series B
- Sekisui Chemical — Series B
- Development Bank of Japan (https://capitalatlas.ai/funds/development-bank-of-japan) — Series B